A Novel RP-HPLC Method For Analysis of Paracetamol Pseudo Ephedrine, Caffeine and
A Novel RP-HPLC Method For Analysis of Paracetamol Pseudo Ephedrine, Caffeine and
A Novel RP-HPLC Method For Analysis of Paracetamol Pseudo Ephedrine, Caffeine and
ABSTRACT
OBJECTIVE: To develop a RP-HPLC method for the determination of Caffeine, Paracetamol, Pseudoephedrine hydrochloride and Chlorpheniramine maleate in
pharmaceutical products.METHOD: HPLC analysis was carried out by using a C18 (150mm, 4.6mm and 3µm) column with gradient program. Mobile phase composed
of sol-A: phosphate buffer (1.0g of KH2PO4 in to 1000ml of HPLC water and mixed) and sol-B: acetonitrile. Gradient program was 0-5min, sol-A: 94-94; 5-10min-
sol-A: 94-86; 10-15min- sol-A: 86-54; 15-17min- sol-A: 54-52; 17-20min- sol-A: 52-94 and 20-25min- sol-A: 94-94. Flow for mobile phase elution is 1.0ml per min;
column oven temperature is maintained at 40°C and measured the absorbance at 210nm. HPLC water is used as diluent.RESULTS: Paracetamol, Pseudoephedrine HCl,
Caffeine and Chlorpheniramine maleate were eluted at 6.5min, 9.7min, 12.0min and 16.2min, respectively. Percent relative standard deviation for five replicate
standard injections area is below 1.5. The method was validated with specificity, precision, linearity, accuracy, ruggedness and robustness. The response was linear over
the concentration range of 10 to 60 µg per mL for each ingredient, with correlation coefficients value is greater than 0.999. Recovery results were between 98 percent
to 102 percent. CONCLUSION: The developed RP-HPLC method is single and reproducible, with high resolution and has been successfully applied for the analysis
of Caffeine, Paracetamol, Pseudoephedrine hydrochloride and Chlorpheniramine maleate in pharmaceutical drug products.
Key words: Caffeine, Paracetamol, Pseudoephedrine HCl and Chlorpheniramine maleate, RP-HPLC method development and validation.
INTRODUCTION
Pharmaceutical drug products formulated with individual or combination dosage forms. Table-1: List of available combinations.
These dosage forms require qualitative and quantitative analytical methods for the determina- Dosage forms Composition
tion of each active ingredient. In this present study, developed a single RP-HPLC method for
the analysis of Caffeine, Paracetamol, Pseudoephedrine hydrochloride and Chlorpheniramine Tablets Paracetamol-125mg, 250mg, 500mg, 650mg and 1000mg
Maleate in pharmaceutical products. Syrup Paracetamol-125mg per 5mL
Drops Paracetamol-150mg per 1mL
Suppository Paracetamol-80mg and 170mg
Caffeine (1-6) is a xanthine alkaloid (psychoactive stimulant). Caffeine has some legitimate Suspension Paracetamol-240mg per 5mL
medical uses in athletic training and in the relief of tension-type headaches. It is a drug that is Injection Paracetamol-150mg,
naturally produced in the leaves and seeds of many plants. It’s also produced artificially and Infusion Paracetamol-1000mg per 100mL
Tablets Paracetamol-500mg and Caffeine-25mg
added to certain foods. Caffeine is defined as a drug because it stimulates the central nervous Paracetamol-6500mg and Caffeine-30mg
system, causing increased alertness. Caffeine gives most people a temporary energy boost and Tablets Chlorpheniramine maleate-4mg
elevates mood. The source of caffeine is in tea, coffee, chocolate, many soft drinks and pain Tablets Caffeine-30mg, Chlorpheniramine maleate-2mg, Paracetamol-500mg and Pseudoephe
relievers. In its natural form, caffeine tastes very bitter but most caffeinated drinks have gone drine HCl-60mg
Caffeine-20mg, Chlorpheniramine maleate-4mg, Paracetamol-500mg and Pseudoephe
through enough processing to camouflage the bitter taste. Overdose of caffeine may cause drine HCl-60mg
Tablets Caffeine citrate-20mg
Tablets Caffeine-30mg, Chlorpheniramine maleate-2mg and Paracetamol-650mg
Caffeine-25mg, Chlorpheniramine maleate-4mg and Paracetamol-500mg
Tablets Acetaminophen-400mg, Caffeine anhydrous-30mg, Chlorpheniramine maleate-4mg
Quantification:
% of content = Area of test solution x Std. Concentration x average weight x Potency of standard
Area of standard solution x sample concentration x Label claim
Method optimization:
A single and high resolution RP-HPLC method has been developed for the quantification of
Caffeine, Paracetmol, Pseudoephedrine hydrochloride and Chlorpheniramine Maleate in phar-
maceutical formulations. Initial stage of method development, trials were performed with a
mixture of ammonium acetate buffer and acetonitrile with C18, 250mm column but separation
was not achieved. Finally the separation was achieved with phosphate buffer and acetonitrile
with simple gradient program. Diluent and standard solution chromatograms were represented
in figure-2 and 3. Peak shape, resolution (not less than 4.0) and tailing factor (not more than
1.5) were within the limit.
0.30
0.20
AU
Active Ingredient Name Standard solution Area Active Ingredient Name Sample preparations Average (%)
Inj-1 Inj-2 Inj-3 Inj-4 Inj-5 Average %RSD Prep-1 Prep-2 Prep-3 Prep-4 Prep-5 Prep-6
Paracetamol 1032506 1046366 1044300 1033925 1015106 1034440 1.20 Paracetamol 99.81 99.36 98.85 99.3 99.36 98.7 99.23
Pseudoephedrine HCl 739968 747581 742207 749599 727713 741413 1.16 Pseudoephedrine HCl 100.16 99.00 100.1 99.62 100.1 99.09 99.68
Caffeine 2464124 2417813 2484964 2487315 2460809 2463004 1.13 Caffeine 99.75 99.74 99.81 99.78 99.81 99.18 99.68
Chlorpheniramine maleate 642030 626598 644278 645360 639925 639638 1.18 Chlorpheniramine maleate 99.41 99.92 99.24 99.74 100.33 99.78 99.74
Chloropheniramine - 16.264
precision, accuracy and specificity. The complete results proved that the developed method to
0.30 be convenient and effective for the determination of all active ingredients during the analysis of
Caffeine - 12.095
Paracetamol - 6.530
0.20
REFERENCESS
' 1. Armstrong, Lawrence E, Casa Douglas J, Maresh, Carl M and Ganio and S Matthew, Caffeine,
0.10 Fluid-Electrolyte Balance, Temperature Regulation, and Exercise-Heat Tolerance, Exercise and
Sport Sciences Reviews, 2007, 35 (3), 135–140.
2. Armstrong LE, Pumerantz AC, Roti MW, Judelson DA, Watson G, Dias JC, Sokmen B and DJ Casa,
0.00 Fluid, electrolyte and renal indices of hydration during 11 days of controlled caffeine consumption,
6.00 8.00 10.00 12.00 14.00 16.00 International Journal of Sport Nutrition and Exercise Metabolism, 2005, 15 (3), 252–265.
Minutes 3. Frischknecht Peter M, Ulmer-Dufek Jindra and W Baumann Thomas, Purine alkaloid formation
Figure-6: Linearity chromatograms in buds and developing leaflets of Coffea arabica: Expression of an optimal defence strategy, Phyto
chemistry, 1986, 25, 613–616.
Table-5: Linearity Results. 4. BaumannTW, Metabolism and excretion of caffeine during germination of Coffea arabica L, Plant
Active Ingredient Name Linearity solutions area and Cell Physiology, 1984, 25 (8), 1431–1436.
Level-1 Level-2 Level-3 Level-4 Level-5 Level-6 Co-relation 5. Matissek R, Evaluation of xanthine derivatives in chocolate: nutritional and chemical aspects,
(10ppm) (20ppm) (30ppm) (40ppm) (50ppm) (60ppm) Coefficient European Food Research and Technology, 1997, 205 (3), 175–184.
6. Meyer FP, Canzler E, Giers H and H Walther, Time course of inhibition of caffeine elimination
Paracetamol 220834 501226 775388 1053476 1324473 1615435 0.99996 in response to the oral depot contraceptive agent Deposiston, Hormonal contraceptives and caf-
Pseudoephedrine HCl 154748 354840 548999 748824 945629 1153341 0.99996 feine elimination, Zentralbl Gynakol, 1991, 113 (6), 297–302.
Caffeine 525802 1192511 1834561 2487823 3124217 3804145 0.99997 7. Granberg RA and AC Rasmuson, Solubility of paracetamol in pure solvents, Journal of Chemical
Chlorpheniramine maleate 135283 309801 475354 648731 816912 996747 0.99995 and Engineering Data, 1999, 44 (6), 1391–1395.
8. Moller, P, Sindet-Pedersen S, Petersen C, Juhl G, Dillenschneider A and L Skoglund, Onset of
Accuracy: acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery,
To study the reliability and accuracy of the method, recovery experiments were carried out with British Journal of Anaesthesia, 2005, 94 (5): 642–648.
a known quantity of the pure drug was added to the placebo sample at the level of 25% to 150% 9. www.Acetaminophen Drugs.com
of the test concentration. The contents were determined from the respective chromatograms. 10. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R and S Leone, Paracetamol: new vistas of an
old drug, CNS Drug Reviews, 2006, 12 (3–4), 250–275.
The concentration of the drug product in the solution was determined. The mean recoveries 11. Acetaminophen, chemicalland21.com, 2011.
were in range of 98.0-102.0 % which shows that there is no interference from excipients. Table- 12. Viswanathan AN, Feskanich D, Schernhammer ES and SE Hankinson, Aspirin, NSAID and Ac-
6 represents the recovery results. etaminophen Use and the Risk of Endometrial Cancer, Cancer Research, 2008, 68 (7), 2507.
13. Altinoz MA, Korkmaz R and B NF-kappa, Macrophage migration inhibitory factor and
Table-6: Accuracy (recovery) Results. cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-pre-
Active Ingredient Name Spike level Average % vention of the ovarian cancer, Neoplasma, 2004, 51 (4), 239–247.
25% 50% 75% 100% 125% 150% Recovery 14. Byrant, Bronwen, Knights, Katleen, Salerno and Evelyn, Pharmacology for health professionals,
Elsevier, 2007, 270.
Paracetamol 98.70 99.71 99.36 99.18 101.34 99.76 99.68 15. Kiyoshi Minamizawa, Effect of d-Pseudoephedrine on cough reflex and it’s mode of action in
Pseudoephedrine HCl 99.09 99.94 100.34 99.78 99.24 99.73 99.69 guinea pigs, Journal of Pharmacological Sciences, 2006, 102 (1), 136-142.
Caffeine 99.18 99.91 100.58 99.46 99.86 99.46 99.74 16. Bicopoulos D, Drug information for the healthcare professional, Castle Hill: Pharmaceutical Care
Chlorpheniramine maleate 99.78 99.81 99.63 99.73 100.92 99.73 99.93 Information Services, 2002, 2nd edition.
17. Rossi S, Australian Medicines Handbook, Adelaide: Australian Medicines Handbook, 2006.
Ruggedness: 18. Vidal C, Prieto A, Pérez-Carral C and M Armisén, Non pigmenting fixed drug eruption due to
The ruggedness of the method was determined by carrying out the experiment on different pseudoephedrine, Ann Allergy Asthma Immunology, 1998, 80 (4), 309–310.
instruments like waters HPLC and Agilent HPLC by different operators using different 19. Carlsson A and M Linqvist, Central and peripheral monoaminergic membrane-pump blockade by
some addictive analgesics and antihistamines, Journal of Pharmaceutical Pharmacology,
columns of similar types. The percent RSD of six different preparations for all active ingredi- 1969, 21 (7), 460–464.
ents assay values with two different instruments, analysts and columns were within the limit. 20. Hellbom E, Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter
(OTC) treatment, Medical Hypotheses, 2006, 66 (4), 689–690.
Table-7: Robustness Results. 21. Edward F Domino, History of Modern Psychopharmacology: A Personal View with an Emphasis
Parameter System suitability on Antidepressants, Psychosomatic Medicine, 1999, 61, 591-598.
Variation Tailing factor Percent (%) RSD 22. International Conference on Harmonization, Q2A: Text on Validation of Analytical Procedures,
Federal Register, 1995, 60(40), 11260–11262.
Standard solution ——- 1.1-1.3 1.2-1.5 23. International Conference on Harmonization, Q2B: Validation of Analytical Procedures: Method-
Flow Rate +0.1mL per min 0.8-1.0 0.8-1.2 ology and Availability, Federal Register, 1997, 62 (96), 27463–27467.
-0.1mL per min 0.9-1.1 0.9-1.2 24. FDA, Analytical Procedures and Methods Validation: Chemistry, Manufacturing and Controls
Column Oven Temperature +5°C 1.1-1.5 1.0-1.2 Documentation, Availability, Federal Register, 2000, 65(169), 52776–52777.
-5°C 1.2-1.4 1.1-1.3 25. www.fda.gov/cder/guidance/cmc3.pdf
26. USP 25–NF 20, Validation of Compendial Methods Section (1225) (United States Pharmacopeal
Robustness: Convention, Rockville, Maryland, USA, 2002), 2256.
Robustness of the method was determined by making slight changes in the chromatographic